Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RIRS for Treatment of Stones in Congenital Anomalous Kidneys

NCT: NCT05240170 · COMPLETED

NCT IDNCT05240170
StatusCOMPLETED
Start Date2022-03-15
Completion2024-07-15
SponsorAl-Azhar University (OTHER)
First posted
Last updated

Brief Summary

The anatomic renal abnormalities like altered spatial relations with adjacent organs, abnormal calyceal orientation, and anomalous vascular patterns make the active treatment of stones in the congenitally malformed kidney a great challenge for urologists. In this prospective study, the investigators will evaluate the outcome of retrograde intrarenal surgery (RIRS) with extracorporeal shockwave lithotripsy (SWL) for the treatment of stones in the kidneys with rotation or position anomalies.

Frequently Asked Questions

What is RIRS for Treatment of Stones in Congenital Anomalous Kidneys?

RIRS for Treatment of Stones in Congenital Anomalous Kidneys is a clinical trial registered under NCT05240170. Current status: COMPLETED.

What is the status of NCT05240170?

The current status of NCT05240170 (RIRS for Treatment of Stones in Congenital Anomalous Kidneys) is: COMPLETED.

When did RIRS for Treatment of Stones in Congenital Anomalous Kidneys start?

RIRS for Treatment of Stones in Congenital Anomalous Kidneys started on 2022-03-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.